Seizure localization for epilepsy surgery using high frequency electrophysiological markers
使用高频电生理标记进行癫痫手术的癫痫发作定位
基本信息
- 批准号:10606373
- 负责人:
- 金额:$ 8.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-15 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AccountingAnticonvulsantsAntiepileptic AgentsAreaBiological MarkersBlindedBrainBrain imagingBrain regionCharacteristicsClassificationClinicalClinical TrialsComplexCoupledDataDecision MakingDetectionElectrocorticogramElectrodesElectroencephalographyElectrophysiology (science)EpilepsyEventExcisionFailureFreedomFrequenciesGoalsHigh Frequency OscillationImplantImplanted ElectrodesIndividualIntuitionKnowledgeMeasurementMeasuresMethodologyMethodsModelingMonitorMorphologyOperative Surgical ProceduresOutcomePathologicPatient-Focused OutcomesPatientsPharmaceutical PreparationsPhysiologicalPostoperative PeriodProceduresProspective StudiesQuality of lifeRecommendationResearchResectedSeizuresSensitivity and SpecificitySignal TransductionSpecificitySurfaceSurgeonSurgical ManagementTechniquesTestingTissuesVisionWorkbrain electrical activitybrain tissuechildhood epilepsyclinical implementationcomputerized toolsdensityhigh standardimprovedimproved outcomeminimally invasiveneurotransmissionnovelprospectiverisk minimizationsimulation
项目摘要
PROJECT SUMMARY/ABSTRACT
In the most severe cases of epilepsy, where seizures persist despite multiple trials of anti-seizure medications,
patients may benefit from surgical removal of seizure-generating brain tissue. Prior to surgery, electrodes are
often implanted directly into or onto the patient’s brain and are used to continuously record electrical brain
activity over days. This is done to capture seizure activity and determine its point of origin, i.e. the seizure
onset zone. If the seizure onset zone is identified, clinicians then use this information, in combination with the
results of brain imaging and other testing, to guide removal of the corresponding brain tissue. While epilepsy
surgery may lead to seizure freedom, 70-90% of surgery patients remain on anti-seizure medications and
roughly 50% of patients continue to have seizures. The long-term goal of this work is to improve the outcomes
of patients undergoing epilepsy surgery by developing more accurate methods to localize seizure-generating
tissue. High frequency oscillations (HFOs) have garnered considerable excitement for their potential to identify
and localize epileptogenic brain tissue. HFOs are short bursts of high-frequency electrical activity that occur in
the brains of patients with epilepsy. They occur more frequently in the epileptogenic zone (EZ, the hypothetical
area that must be excised to attain post-operative seizure freedom), and surgically removing HFO-generating
brain tissue increases the likelihood of seizure freedom. While ongoing clinical trials are attempting to assess
their prospective value for epilepsy surgery planning, there are multiple barriers to their widespread use. While
group-level results are robust, HFO analysis is not yet predictive for single subjects. Recordings lack the
sensitivity to reliably measure HFOs in every patient, and the occurrence of non-epileptic HFOs confounds the
results. Therefore, HFOs are poised to revolutionize epilepsy surgery, but there is a critical need to optimize
their measurement and maximize single-subject accuracy. The overall objective of this proposal is to improve
EZ localization accuracy through systematic determination of the optimal HFO measurement methodology,
coupled with novel, robust methods for HFO analysis. The rationale is that developing these novel methods
with improved measurement techniques will increase the accuracy and robustness of HFOs as a biomarker of
the seizure onset zone, thus improving the surgical management of epilepsy. To attain our objective, we will
pursue three specific aims: (1) Demonstrate that electrode size is a crucial factor in HFO measurement. (2)
Develop an automated method for patient-specific localization of the EZ based on HFOs. (3) Evaluate the
effects of electrode size and HFO analysis method on EZ localization. The proposed research is significant
because it will provide specific recommendations for the measurement and analysis of HFOs, enabling
accurate, detailed localization of epileptogenic brain tissue. The expected outcome of this work is that it will
guide surgeons in choosing which brain regions to remove and will increase the pool of potential surgical
candidates. Overall, this will have a positive impact by leading to a greater chance of seizure freedom and
improved quality of life for patients with the most severe cases of epilepsy.
项目总结/摘要
在最严重的癫痫病例中,尽管进行了多次抗癫痫药物试验,
患者可受益于手术切除产生肿瘤的脑组织。在手术之前,
通常直接植入患者的大脑中或大脑上,
活动日。这样做是为了捕捉癫痫发作活动并确定其起源点,即癫痫发作
起始区如果识别出癫痫发作区,则临床医生随后将该信息与
脑成像和其他测试的结果,以指导相应脑组织的切除。虽然癫痫
手术可能导致癫痫发作的自由,70-90%的手术患者保持抗癫痫药物,
大约50%的病人会继续癫痫发作这项工作的长期目标是改善成果
通过开发更准确的方法来定位癫痫发生,
组织.高频振荡(HFO)因其识别
定位致癫痫脑组织HFO是高频电活动的短暂爆发,
癫痫病人的大脑它们更频繁地发生在致痫区(EZ,假设的
必须切除以获得术后癫痫发作自由的区域),并通过手术切除产生HFO的
脑组织会增加癫痫发作的可能性虽然正在进行的临床试验试图评估
虽然它们对癫痫手术规划的前瞻性价值,但它们的广泛使用存在多种障碍。而
组水平的结果是稳健的,HFO分析还不能预测单个受试者。记录缺乏
可靠地测量每个患者的HFO的灵敏度,非癫痫HFO的发生混淆了
结果因此,HFO有望彻底改变癫痫手术,但迫切需要优化
最大限度地提高单个受试者的准确性。本建议的总体目标是改善
通过系统地确定最佳HFO测量方法来提高EZ定位精度,
再加上新的,强大的HFO分析方法。基本原理是,开发这些新方法
随着测量技术的改进,将提高HFO作为生物标志物的准确性和鲁棒性。
癫痫发作区,从而改善癫痫的外科治疗。为了实现我们的目标,我们将
具体目标有三:(1)证明电极尺寸是HFO测量的关键因素。(二)
开发基于HFO的患者特定EZ定位的自动化方法。(3)评价
电极尺寸和HFO分析方法对EZ定位的影响。所提出的研究是有意义的
因为它将为氢氟烯烃的测量和分析提供具体建议,从而使
准确详细地定位致癫痫脑组织这项工作的预期成果是,
指导外科医生选择要切除的大脑区域,
候选人总的来说,这将产生积极的影响,导致更大的机会癫痫发作的自由,
改善最严重癫痫患者的生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Beth Ann Lopour其他文献
Beth Ann Lopour的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Beth Ann Lopour', 18)}}的其他基金
Bridging the micro and macro scales of seizure dynamics
连接癫痫动力学的微观和宏观尺度
- 批准号:
10574151 - 财政年份:2022
- 资助金额:
$ 8.08万 - 项目类别:
Seizure localization for epilepsy surgery using high frequency electrophysiological markers
使用高频电生理标记进行癫痫手术的癫痫发作定位
- 批准号:
10368114 - 财政年份:2021
- 资助金额:
$ 8.08万 - 项目类别:
Seizure localization for epilepsy surgery using high frequency electrophysiological markers
使用高频电生理标记进行癫痫手术的癫痫发作定位
- 批准号:
10211944 - 财政年份:2021
- 资助金额:
$ 8.08万 - 项目类别:
Seizure localization for epilepsy surgery using high frequency electrophysiological markers
使用高频电生理标记进行癫痫手术的癫痫发作定位
- 批准号:
10570953 - 财政年份:2021
- 资助金额:
$ 8.08万 - 项目类别:
相似海外基金
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10004277 - 财政年份:2020
- 资助金额:
$ 8.08万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10475298 - 财政年份:2020
- 资助金额:
$ 8.08万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10013749 - 财政年份:2020
- 资助金额:
$ 8.08万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10693904 - 财政年份:2020
- 资助金额:
$ 8.08万 - 项目类别:
Study on how anticonvulsants affect car driving
抗惊厥药如何影响汽车驾驶的研究
- 批准号:
20K17977 - 财政年份:2020
- 资助金额:
$ 8.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10266034 - 财政年份:2020
- 资助金额:
$ 8.08万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10475109 - 财政年份:2020
- 资助金额:
$ 8.08万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10248384 - 财政年份:2020
- 资助金额:
$ 8.08万 - 项目类别:
Prevention of neuropathic pain by antidepressants and anticonvulsants: in vivo patch-clamp analysis
抗抑郁药和抗惊厥药预防神经性疼痛:体内膜片钳分析
- 批准号:
24592355 - 财政年份:2012
- 资助金额:
$ 8.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Anticonvulsants, ischemic seizures and regeneration in the immature brain
抗惊厥药、缺血性癫痫发作和未成熟大脑的再生
- 批准号:
8492175 - 财政年份:2009
- 资助金额:
$ 8.08万 - 项目类别: